
KKR is acquiring a 100% stake in Medicover India, the parent of Sahrudaya Health Care, for about €1.2 billion (roughly Rs 11,400 crore). The seller, Medicover's holding company, held around 65% in…
KKR is acquiring a 100% stake in Medicover India, the parent of Sahrudaya Health Care, for about €1.2 billion (roughly Rs 11,400 crore). The seller, Medicover's holding company, held around 65% in Sahrudaya Health Care Private Limited, which operates 26 hospitals across Telangana, Andhra Pradesh, Karnataka and Maharashtra. AZB & Partners advised KKR, while Cyril Amarchand Mangaldas and McDermott Will & Schulte represented Medicover. The transaction is subject to regulatory approvals and is expected to close in the fourth quarter of 2026.

Private equity buying Indian hospital chains at high multiples is now routine, but this deal says more about KKR's appetite than about the sector's health. The headline €1.2 billion looks impressive, yet the underlying story is a seller, Medicover, exiting a 65% stake it held through a holding company. The question Indian patients should ask: will KKR keep the 26 hospitals affordable, or pressure margins to service its own returns? Watch the chain's pricing policy in the next two years for the real answer.
Source: legal.economictimes.indiatimes.com
This story was synthesised by AI from the source linked above.